Up to 10% of all cancer patients will develop metastatic spinal cord compression (MSCC) during the course of their disease. 
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Radiotherapy (RT) is the most frequently applied treatment modality, either alone or following decompressive surgery. The indication for surgery of MSCC is usually limited to patients with solid tumours, involvement of only one spinal segment, a good performance status and a relatively favourable survival prognosis. 2 Thus, RT alone is the most commonly used modality in the treatment of MSCC. The optimal radiation fractionation regimen is still a matter of debate. As many MSCC patients are debilitated, a shorter overall treatment time would be preferable if it provided similar results to more protracted regimens.
Several retrospective and prospective studies have demonstrated that short-course RT with lower total doses (overall treatment time one week or less) achieved similar results to long-course RT with higher total doses (overall treatment time two to four weeks) in terms of post-treatment motor function and pain relief. [3] [4] [5] [6] [7] [8] Thus, short-course RT may be considered for the treatment of MSCC. This particularly applies to patients with a poor expected survival of only a few months. By using a short-course RT regimen, the need for these patients to spend a considerable proportion of their limited lifespan receiving treatment may be decreased.
By contrast, a considerable proportion of MSCC patients live much longer than a few months. 9 Some patients live for years. As the vast majority of recurrences of MSCC in the previously irradiated area of the spinal cord develop at only six months or later following irradiation, patients with a more favourable survival prognosis are at a higher risk of developing a local recurrence. Due to the rather limited indications for surgery, re-irradiation is the primary treatment option for many of these recurrences. 2 However, re-irradiation may carry an increased risk of radiation-related myelopathy that may be associated with severe neurological deficits. Therefore, both posttreatment neurological function and local control are important end-points following irradiation of MSCC. This article focuses on local control of MSCC following irradiation. The impact of fractionation, potential prognostic factors and the option of spinal re-irradiation of a local recurrence are reviewed.
Impact of the Fractionation Regimen
Many different fractionation regimens are used worldwide for the RT of MSCC. These include single-fraction regimens such as 1x8Gy, multifraction short-course regimens such as 4x4Gy over four days, 5x4Gy over one week or 5x5Gy over one week, and multifraction long- Evaluation 1 (SCORE-1) study was started. 10 The primary goal of the SCORE-1 study was to evaluate whether short-course RT with 1x8Gy over one day or 5x4Gy over one week results over similar local control of MSCC to long-course RT with 10x3Gy over two weeks, have recently been presented in abstract form. 10 The local control rate at 12 months was 81% after long-course RT and 61% after shortcourse RT (p=0.005). These results were confirmed in a multivariate analysis (p=0.018). Studies from other authors did not often focus on local control. In a randomised study of 276 patients, the median duration of improvement in motor function was 3.5 months following both 1x8Gy and a split-course regimen (3x5Gy followed by one-week rest and 5x3Gy). 6 In another randomised study of 327 patients by the same authors, the median duration of improvement in motor function was 4.5 months after 1x8Gy compared with five months after 2x8Gy in eight days (p=0.4). 8 However, these authors did not differentiate between recurrences within (in-field recurrence) or outside (out-field recurrence) the previously irradiated area of the spinal cord. Therefore, while these studies are helpful in terms of functional outcomes, they are not particularly helpful if one aims to define the optimal fractionation regime in terms of local control.
The reported studies that focused on local control (freedom from in-field recurrence) of MSCC suggested that long-course RT is superior to short-course or single-fraction regimens. 7, 9, 10 The fact that significantly more MSCC recurrences were observed after short-course RT than after long-course RT can be explained by the higher total radiation doses given in the long-course protocols 
Other Potential Prognostic Factors
The above-mentioned study of 1,852 patients further aimed to identify potential prognostic factors in terms of local control of MSCC. 9 In the univariate analysis, the type of primary tumour and visceral metastases at the time of RT were associated with local control of MSCC. The one-year local control rates were 94% for myeloma patients, 92% for breast cancer patients, 84% for prostate cancer patients, 79% for lung cancer patients and 83% for patients with other tumours (p<0.001). In patients without visceral
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Predicting the Survival Prognosis of Patients Irradiated for Metastatic Spinal Cord Compression
Long-course RT appears the better option for MSCC patients with a favourable survival prognosis, as these patients may live long enough to develop a recurrence of MSCC in the previously irradiated area of the spinal cord. A scoring system helping to predict the survival prognosis of MSCC patients could be helpful to select the most appropriate radiation regimen for the individual patient.
Based on the multivariate analysis of the retrospective study of 1,852
MSCC patients treated with RT alone, just such a scoring system was developed. 12 In the multivariate analysis, six factors were significantly associated with survival. These factors were type of primary tumour days). The score for each prognostic factor was determined by dividing the six-month survival rate (given in %) by 10 (see Table 1 ). The six-month survival rates were 4% for patients with 20-25 points, 11% for those with 26-30 points, 48% for those with 31-35 points, 87% for those with 36-40 points and 99% for those with 41-45 points (p<0.0001) (see Table 2 ). Subgroup analyses were performed for each group comparing short-course RT with longercourse RT. Patients with 36 points had significantly longer survival with long-course than with short-course RT. Those with scores <36 points had similar survival with either short-or longer-course RT.
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Thus, patients with 36 points should receive longer-course RT and those with <36 points should receive short-course RT. Patients with >41 points may be considered candidates for lower doses per fraction or for high-precision RT techniques such as intensitymodulated RT (IMRT), radiosurgery, fractionated stereotactic body RT (FSBRT) or proton beams in order to maximise local control and reduce the risk of potential radiation-related late morbidity. [13] [14] [15] In a retrospective series of 18 patients receiving re-irradiation with IMRT and/or FSBRT, improvement of neurological deficits was observed in 42%. 14 In another retrospective series, neurological deficits improved in 84% (27/32) of the patients after Cyberknife ® radiosurgery as primary treatment.
15
Re-irradiation of a Local Recurrence of Metastatic Spinal Cord Compression
A second episode of MSCC occurs in <14% of the previously irradiated patients. of the patients. 18 However, if an in-field recurrence develops after primary long-course RT with a higher EQD2, a second course of RT to the same area of the spinal cord may not be considered safe in many cases. These patients should be considered for treatment with highprecision RT techniques. 
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